111 related articles for article (PubMed ID: 29044829)
21. Activation of mutant enzyme function in vivo by proteasome inhibitors and treatments that induce Hsp70.
Singh LR; Gupta S; Honig NH; Kraus JP; Kruger WD
PLoS Genet; 2010 Jan; 6(1):e1000807. PubMed ID: 20066033
[TBL] [Abstract][Full Text] [Related]
22. A novel transgenic mouse model of CBS-deficient homocystinuria does not incur hepatic steatosis or fibrosis and exhibits a hypercoagulative phenotype that is ameliorated by betaine treatment.
Maclean KN; Sikora J; Kožich V; Jiang H; Greiner LS; Kraus E; Krijt J; Overdier KH; Collard R; Brodsky GL; Meltesen L; Crnic LS; Allen RH; Stabler SP; Elleder M; Rozen R; Patterson D; Kraus JP
Mol Genet Metab; 2010; 101(2-3):153-62. PubMed ID: 20638879
[TBL] [Abstract][Full Text] [Related]
23. Treatment of Cystathionine β-Synthase Deficiency in Mice Using a Minicircle-Based Naked DNA Vector.
Lee HO; Gallego-Villar L; Grisch-Chan HM; Häberle J; Thöny B; Kruger WD
Hum Gene Ther; 2019 Sep; 30(9):1093-1100. PubMed ID: 31084364
[TBL] [Abstract][Full Text] [Related]
24. Engineering and Characterization of an Enzyme Replacement Therapy for Classical Homocystinuria.
Majtan T; Park I; Carrillo RS; Bublil EM; Kraus JP
Biomacromolecules; 2017 Jun; 18(6):1747-1761. PubMed ID: 28431470
[TBL] [Abstract][Full Text] [Related]
25. Taurine treatment prevents derangement of the hepatic γ-glutamyl cycle and methylglyoxal metabolism in a mouse model of classical homocystinuria: regulatory crosstalk between thiol and sulfinic acid metabolism.
Maclean KN; Jiang H; Aivazidis S; Kim E; Shearn CT; Harris PS; Petersen DR; Allen RH; Stabler SP; Roede JR
FASEB J; 2018 Mar; 32(3):1265-1280. PubMed ID: 29101223
[TBL] [Abstract][Full Text] [Related]
26. The c.797 G>A (p.R266K) cystathionine β-synthase mutation causes homocystinuria by affecting protein stability.
Gupta S; Wang L; Kruger WD
Hum Mutat; 2017 Jul; 38(7):863-869. PubMed ID: 28488385
[TBL] [Abstract][Full Text] [Related]
27. Recombinant adeno-associated virus mediated gene transfer in a mouse model for homocystinuria.
Park ES; Oh HJ; Kruger WD; Jung SC; Lee JS
Exp Mol Med; 2006 Dec; 38(6):652-61. PubMed ID: 17202841
[TBL] [Abstract][Full Text] [Related]
28. Targeting Cystathionine Beta-Synthase Misfolding in Homocystinuria by Small Ligands: State of the Art and Future Directions.
Majtan T; Pey AL; Ereño-Orbea J; Martínez-Cruz LA; Kraus JP
Curr Drug Targets; 2016; 17(13):1455-70. PubMed ID: 26931358
[TBL] [Abstract][Full Text] [Related]
29. N-Homocysteinylation impairs collagen cross-linking in cystathionine β-synthase-deficient mice: a novel mechanism of connective tissue abnormalities.
Perła-Kajan J; Utyro O; Rusek M; Malinowska A; Sitkiewicz E; Jakubowski H
FASEB J; 2016 Nov; 30(11):3810-3821. PubMed ID: 27530978
[TBL] [Abstract][Full Text] [Related]
30. Contrasting behaviors of mutant cystathionine beta-synthase enzymes associated with pyridoxine response.
Chen X; Wang L; Fazlieva R; Kruger WD
Hum Mutat; 2006 May; 27(5):474-82. PubMed ID: 16619244
[TBL] [Abstract][Full Text] [Related]
31. Cystathionine beta synthase expression in mouse retina.
Markand S; Tawfik A; Ha Y; Gnana-Prakasam J; Sonne S; Ganapathy V; Sen N; Xian M; Smith SB
Curr Eye Res; 2013 May; 38(5):597-604. PubMed ID: 23470016
[TBL] [Abstract][Full Text] [Related]
32. Cystathionine beta-synthase mutations in homocystinuria.
Kraus JP; Janosík M; Kozich V; Mandell R; Shih V; Sperandeo MP; Sebastio G; de Franchis R; Andria G; Kluijtmans LA; Blom H; Boers GH; Gordon RB; Kamoun P; Tsai MY; Kruger WD; Koch HG; Ohura T; Gaustadnes M
Hum Mutat; 1999; 13(5):362-75. PubMed ID: 10338090
[TBL] [Abstract][Full Text] [Related]
33. Potential Pharmacological Chaperones for Cystathionine Beta-Synthase-Deficient Homocystinuria.
Majtan T; Pey AL; Gimenez-Mascarell P; Martínez-Cruz LA; Szabo C; Kožich V; Kraus JP
Handb Exp Pharmacol; 2018; 245():345-383. PubMed ID: 29119254
[TBL] [Abstract][Full Text] [Related]
34. Neutral aminoaciduria in cystathionine β-synthase-deficient mice; an animal model of homocystinuria.
Akahoshi N; Kamata S; Kubota M; Hishiki T; Nagahata Y; Matsuura T; Yamazaki C; Yoshida Y; Yamada H; Ishizaki Y; Suematsu M; Kasahara T; Ishii I
Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1462-76. PubMed ID: 24761004
[TBL] [Abstract][Full Text] [Related]
35. Constitutive induction of pro-inflammatory and chemotactic cytokines in cystathionine beta-synthase deficient homocystinuria.
Keating AK; Freehauf C; Jiang H; Brodsky GL; Stabler SP; Allen RH; Graham DK; Thomas JA; Van Hove JL; Maclean KN
Mol Genet Metab; 2011 Aug; 103(4):330-7. PubMed ID: 21601502
[TBL] [Abstract][Full Text] [Related]
36. Cystathionine β-synthase-deficient mice thrive on a low-methionine diet.
Gupta S; Melnyk SB; Kruger WD
FASEB J; 2014 Feb; 28(2):781-90. PubMed ID: 24189943
[TBL] [Abstract][Full Text] [Related]
37. Vision of correction for classic homocystinuria.
Koeberl DD
J Clin Invest; 2016 Jun; 126(6):2043-4. PubMed ID: 27183384
[TBL] [Abstract][Full Text] [Related]
38. Hypermethioninemia Leads to Fatal Bleeding and Increased Mortality in a Transgenic I278T Mouse Model of Homocystinuria.
Park I; Johnson LK; Cox A; Branchford BR; Di Paola J; Bublil EM; Majtan T
Biomedicines; 2020 Jul; 8(8):. PubMed ID: 32722248
[TBL] [Abstract][Full Text] [Related]
39. High prevalence of cerebral venous sinus thrombosis (CVST) as presentation of cystathionine beta-synthase deficiency in childhood: molecular and clinical findings of Turkish probands.
Karaca M; Hismi B; Ozgul RK; Karaca S; Yilmaz DY; Coskun T; Sivri HS; Tokatli A; Dursun A
Gene; 2014 Jan; 534(2):197-203. PubMed ID: 24211323
[TBL] [Abstract][Full Text] [Related]
40. The molecular basis of cystathionine beta-synthase deficiency in Australian patients: genotype-phenotype correlations and response to treatment.
Gaustadnes M; Wilcken B; Oliveriusova J; McGill J; Fletcher J; Kraus JP; Wilcken DE
Hum Mutat; 2002 Aug; 20(2):117-26. PubMed ID: 12124992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
